PE20020758A1 - Metodo de fabricacion de vacuna combinada - Google Patents

Metodo de fabricacion de vacuna combinada

Info

Publication number
PE20020758A1
PE20020758A1 PE2002000008A PE2002000008A PE20020758A1 PE 20020758 A1 PE20020758 A1 PE 20020758A1 PE 2002000008 A PE2002000008 A PE 2002000008A PE 2002000008 A PE2002000008 A PE 2002000008A PE 20020758 A1 PE20020758 A1 PE 20020758A1
Authority
PE
Peru
Prior art keywords
antigen
combined vaccine
manufacturing
tetano
diphtheria
Prior art date
Application number
PE2002000008A
Other languages
English (en)
Inventor
Kyu-Wan Kim
Hyi-Jeong Ji
Youn-Kyeong Lee
Wan-Kyu Kim
Hee-Ku Lee
Won-Kyum Kim
Original Assignee
Lg Chem Investment Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19704448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020758(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lg Chem Investment Ltd filed Critical Lg Chem Investment Ltd
Publication of PE20020758A1 publication Critical patent/PE20020758A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0016Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0017Combination vaccines based on whole cell diphtheria-tetanus-pertussis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0016Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE REFIERE A UN METODO DE FABRICACION DE UNA VACUNA COMBINADA QUE COMPRENDE LOS PASOS DE: a) ABSORCION QUE PERMITE ADSORBER INDEPENDIENTEMENTE CADA ANTIGENO PROTECTIVO AL ADSORBENTE RESPECTIVO DE DIFERENTES ENFERMEDADES DE MANERA INDEPENDIENTE UN ABSORBENTE COMO GEL DE HIDROXIDO DE ALUMINIO Y b) COMBINACION DE CADA ANTIGENO ABSORBIDO CON EL ADSORBENTE. EL ANTIGENO SE SELECCIONA DE DIFTERIA, TETANO, ANTIGENO DE TOS CONVULSIVA, ANTIGENO DE HEPATITIS B. LA CONCENTRACION DEL ION DE ALUMINIO DESPUES DE LA ELABORACION ESTA ENTRE 0.5 mg/ml Y 1.25 mg/ml. LA PREPARACION COMPRENDE ADEMAS ANADIR UN SURFACTANTE NEUTRAL COMO POLISORBATO 20, POLISORBATO 80 Y TRITON X-100. LA VACUNA COMBINADA ES CAPAZ DE PREVENIR SIMULTANEAMENTE MULTIPLES ENFERMEDADES COMO DIFTERIA, TETANO, TOS CONVULSIVA, HEPATITIS
PE2002000008A 2001-01-10 2002-01-09 Metodo de fabricacion de vacuna combinada PE20020758A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2001-0001290A KR100401423B1 (ko) 2001-01-10 2001-01-10 혼합 백신의 제조 방법

Publications (1)

Publication Number Publication Date
PE20020758A1 true PE20020758A1 (es) 2002-08-29

Family

ID=19704448

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000008A PE20020758A1 (es) 2001-01-10 2002-01-09 Metodo de fabricacion de vacuna combinada

Country Status (21)

Country Link
US (2) US20040048336A1 (es)
EP (1) EP1349572B1 (es)
JP (1) JP3977257B2 (es)
KR (1) KR100401423B1 (es)
CN (1) CN1228086C (es)
AR (1) AR032391A1 (es)
AT (1) ATE373485T1 (es)
AU (1) AU2002219693B2 (es)
BR (1) BR0206391A (es)
CA (1) CA2434421C (es)
DE (1) DE60222529T2 (es)
ES (1) ES2291466T3 (es)
IL (1) IL156791A0 (es)
MX (1) MXPA03006154A (es)
MY (1) MY143688A (es)
PE (1) PE20020758A1 (es)
PL (1) PL211005B1 (es)
RU (1) RU2264226C2 (es)
UY (1) UY27118A1 (es)
WO (1) WO2002055105A1 (es)
ZA (1) ZA200305072B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118963T3 (es) 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
GB0522765D0 (en) 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
WO2007138621A1 (en) * 2006-05-31 2007-12-06 Silvio Buzzi Pharmaceutical use of protein molecules immunologically correlated to diphtheria toxin
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
PL2097102T3 (pl) * 2006-09-07 2012-10-31 Glaxosmithkline Biologicals Sa Szczepionka skojarzona o zmniejszonej ilości antygenu wirusa polio
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
IT1398927B1 (it) 2009-06-25 2013-03-28 Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi Espressione batterica di un gene artificiale per la produzione di crm197 e derivati.
GB0917647D0 (en) 2009-10-08 2009-11-25 Glaxosmithkline Biolog Sa Expression system
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
KR101518473B1 (ko) 2013-03-14 2015-05-07 (주)바이오인디스트 애완견의 바이러스성 전염병 예방 및 치료용 복합 난황 항체 조성물 및 그 제조방법
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MA40920A (fr) * 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
KR20220076405A (ko) * 2020-11-30 2022-06-08 주식회사 엘지화학 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
CA1338800C (en) * 1986-06-17 1996-12-17 Michael Houghton Hepatitis delta and diagnostics and vaccines
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 A型及びb型肝炎混合アジュバントワクチン
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
ES2118963T3 (es) * 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.
JP4229341B2 (ja) * 1996-03-23 2009-02-25 財団法人阪大微生物病研究会 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
JP3280675B2 (ja) * 1996-07-02 2002-05-13 コノート ラボラトリーズ リミテッド 多価dtpポリオワクチン
GB9623233D0 (en) * 1996-11-07 1997-01-08 Smithkline Beecham Biolog Vaccine composition
DE69735191T2 (de) * 1997-09-15 2006-10-05 Sanofi Pasteur Msd Verfahren zur Herstellung multivalenter Impfstoffe
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
EP1349572B1 (en) 2007-09-19
US20090181050A1 (en) 2009-07-16
ES2291466T3 (es) 2008-03-01
CN1228086C (zh) 2005-11-23
WO2002055105A1 (en) 2002-07-18
ATE373485T1 (de) 2007-10-15
CN1484531A (zh) 2004-03-24
UY27118A1 (es) 2002-08-30
KR100401423B1 (ko) 2003-10-17
CA2434421C (en) 2012-02-21
AR032391A1 (es) 2003-11-05
BR0206391A (pt) 2004-07-27
DE60222529D1 (de) 2007-10-31
EP1349572A1 (en) 2003-10-08
MXPA03006154A (es) 2003-09-16
DE60222529T2 (de) 2008-06-19
MY143688A (en) 2011-06-30
IL156791A0 (en) 2004-02-08
RU2264226C2 (ru) 2005-11-20
ZA200305072B (en) 2003-09-17
PL211005B1 (pl) 2012-03-30
KR20020060298A (ko) 2002-07-18
JP3977257B2 (ja) 2007-09-19
CA2434421A1 (en) 2002-07-18
AU2002219693B2 (en) 2006-03-16
RU2003124660A (ru) 2005-01-10
JP2004517866A (ja) 2004-06-17
US20040048336A1 (en) 2004-03-11
PL369433A1 (en) 2005-04-18
EP1349572A4 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
PE20020758A1 (es) Metodo de fabricacion de vacuna combinada
BRPI0506977A (pt) composto de tetrahidrocarbolina como agentes anticáncer
DK1558616T4 (da) Meso-substituerede porphyriner
ECSP055699A (es) Indazoles, benzotiazoles y benzoisotiazoles, y su preparacion y usos
ECSP045310A (es) Material micronizado cristalino del bromuro de tiotropio
CY1105210T1 (el) Μεθοδος για την παρασκευη προδρομου ενωσης του αντιχολινενepγου tiotropiumbromid
ECSP056132A (es) Combinaciones para el tratamiento de enfermedades que implican proliferación, migración o apoptosis celulares de células de mieloma, o angiogénesis
CO4410167A1 (es) Articulo absorbente que tiene una estructura trenzada que absorbe por capilaridad
TW200518209A (en) Transparent amorphous carbon structure in semiconductor devices
PE20011036A1 (es) Productos absorbentes con canales y remojado mejorado
AR025750A1 (es) Vacunas
UY28832A1 (es) Mezclas fungicidas ternarias.
AR049480A1 (es) Usos de los anticuerpos anti-ctla-4
BR0215392A (pt) Composições farmacêuticas compreendendo um inibidor de fosfodiesterase multifuncional e um inibidor de absorção de adenosina, bem como uso das mesmas
AR051765A1 (es) Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas
ES2184756T3 (es) Uso de metioninasa como agente antitumoral en quimioterapia antimetionina.
UY29069A1 (es) Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia
CR9751A (es) Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales.
EP1424942A4 (en) PORPHYRINS WITH EFFICIENT MULTI-PHOTON ABSORPTION SECTION FOR PHOTODYNAMIC THERAPY
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
AR058361A1 (es) Composiciones lifolizadas de un compuesto de triazolopirimidina
SV1999000250A (es) Combinacion de cerivastatina y fibratos ref. lea 33479-sv
ECSP045321A (es) Formulaciones en suspensión con hfa que contienen un anticolinérgico
AR055215A1 (es) Almohadilla difusora de etapas multiples
ES2193424T3 (es) Aminas triciclicas farmaceuticamente activas.

Legal Events

Date Code Title Description
FG Grant, registration